Report on Research Compliance
Please click here for full article
Please click here for full article
A follow-up to news reports about the conflict of interest scandal that has engulfed not only Dr. Charles Nemeroff, former president and editor in chief of the official journal of the American College of Neuropsychopharmacology, but the College itself.
"For patients, navigating the debate can be difficult because doctors, patient advocacy groups and manufacturers often endorse positions that are in their economic self-interest." The New York Times
The World Health Organization provides public health recommendations about the use of pharmacologic drugs and vaccines and provides guidelines and assistance in public health emergencies. When it was founded in 1948, the WHO relied on funding from its member states; their contributions were assessed based on their national income and…
Posted by Meryl Nass, MD Swine flu vaccine-induced narcolepsy is costing European governments over $1 Billion due to liability waivers for manufacturers; and the same waivers were just issued for Ebola vaccines. The UK is paying out about $1.7 million dollars per victim. Although the media rarely reported on the…
“Nothing is more fundamental to the ethical conduct of clinical trials than the informed consent of research participants. The Nuremberg Code and every subsequent major international statement about ethics and medical research enshrine this role.” In his recent article in Science and Engineering Ethics, Dr. Mark Yarborough, Dean’s Professor of…
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby.[1]